Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
NCT07161193
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Autoimmune Diseases
Interventions
BIOLOGICAL:
CD19 CAR-T cells
Sponsor
Hebei Senlang Biotechnology Inc., Ltd.
Collaborators
[object Object]
[object Object]